Adam Graybill

Adam Graybill, co-founder and CEO of Journey Biosciences. With a robust 20-year tenure in the diabetes market, Adam has been at the forefront of assembling purpose-driven teams and forging impactful strategic partnerships across the healthcare landscape; having played an instrumental role in building the Cardinal Health At Home business to a billion-plus dollar entity, ultimately serving over 300,000 individuals with type 1 diabetes each year. Deeply understanding of the demands and burd...